BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 27111850)

  • 1. Characterisation of the Immunomodulatory Effects of Meningococcal Opa Proteins on Human Peripheral Blood Mononuclear Cells and CD4+ T Cells.
    Jones C; Sadarangani M; Lewis S; Payne I; Saleem M; Derrick JP; Pollard AJ
    PLoS One; 2016; 11(4):e0154153. PubMed ID: 27111850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of human CEACAM1 in transgenic mice limits the Opa-specific immune response against meningococcal outer membrane vesicles.
    Zariri A; van Dijken H; Hamstra HJ; van der Flier M; Vidarsson G; van Putten JP; Boog CJ; van den Dobbelsteen G; van der Ley P
    Vaccine; 2013 Nov; 31(47):5585-93. PubMed ID: 23933369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction of Opa-positive and Opa-negative strains of Neisseria meningitidis to evaluate a novel meningococcal vaccine.
    Sadarangani M; Hoe JC; Callaghan MJ; Jones C; Chan H; Makepeace K; Daniels-Treffandier H; Deadman ME; Bayliss C; Feavers I; van der Ley P; Pollard AJ
    PLoS One; 2012; 7(12):e51045. PubMed ID: 23251421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opa+ and Opa- isolates of Neisseria meningitidis and Neisseria gonorrhoeae induce sustained proliferative responses in human CD4+ T cells.
    Youssef AR; van der Flier M; Estevão S; Hartwig NG; van der Ley P; Virji M
    Infect Immun; 2009 Nov; 77(11):5170-80. PubMed ID: 19720754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opa proteins and CEACAMs: pathways of immune engagement for pathogenic Neisseria.
    Sadarangani M; Pollard AJ; Gray-Owen SD
    FEMS Microbiol Rev; 2011 May; 35(3):498-514. PubMed ID: 21204865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Meningococcal Outer Membrane Vesicle Vaccine with Overexpressed Mutant FHbp Elicits Higher Protective Antibody Responses in Infant Rhesus Macaques than a Licensed Serogroup B Vaccine.
    Beernink PT; Vianzon V; Lewis LA; Moe GR; Granoff DM
    mBio; 2019 Jun; 10(3):. PubMed ID: 31213564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal immunisation of mice with liposomes containing recombinant meningococcal OpaB and OpaJ proteins.
    de Jonge MI; Hamstra HJ; Jiskoot W; Roholl P; Williams NA; Dankert J; van Alphen L; van der Ley P
    Vaccine; 2004 Sep; 22(29-30):4021-8. PubMed ID: 15364452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A native outer membrane vesicle vaccine confers protection against meningococcal colonization in human CEACAM1 transgenic mice.
    Pajon R; Buckwalter CM; Johswich KO; Gray-Owen SD; Granoff DM
    Vaccine; 2015 Mar; 33(11):1317-1323. PubMed ID: 25662856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neisserial outer membrane vesicles bind the coinhibitory receptor carcinoembryonic antigen-related cellular adhesion molecule 1 and suppress CD4+ T lymphocyte function.
    Lee HS; Boulton IC; Reddin K; Wong H; Halliwell D; Mandelboim O; Gorringe AR; Gray-Owen SD
    Infect Immun; 2007 Sep; 75(9):4449-55. PubMed ID: 17620353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meningococcal Factor H Binding Protein Vaccine Antigens with Increased Thermal Stability and Decreased Binding of Human Factor H.
    Rossi R; Konar M; Beernink PT
    Infect Immun; 2016 Jun; 84(6):1735-1742. PubMed ID: 27021245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical immunogenicity study of trivalent meningococcal AWX-OMV vaccines for the African meningitis belt.
    Tunheim G; Naess LM; Acevedo R; Fjeldheim ÅK; Bolstad K; García L; Cardoso D; Aase A; Zayas C; González H; Rosenqvist E; Norheim G
    Vaccine; 2014 Nov; 32(49):6631-8. PubMed ID: 25305564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Serogroup B Meningococcal Vaccine Bexsero Elicits Antibodies to Neisseria gonorrhoeae.
    Semchenko EA; Tan A; Borrow R; Seib KL
    Clin Infect Dis; 2019 Sep; 69(7):1101-1111. PubMed ID: 30551148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective antibody responses elicited by a meningococcal outer membrane vesicle vaccine with overexpressed genome-derived neisserial antigen 1870.
    Hou VC; Koeberling O; Welsch JA; Granoff DM
    J Infect Dis; 2005 Aug; 192(4):580-90. PubMed ID: 16028126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy.
    Chen HW; Liao CH; Ying C; Chang CJ; Lin CM
    Clin Immunol; 2006 Apr; 119(1):21-31. PubMed ID: 16406844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional expression of the capsule polymerase of Neisseria meningitidis serogroup X: a new perspective for vaccine development.
    Fiebig T; Berti F; Freiberger F; Pinto V; Claus H; Romano MR; Proietti D; Brogioni B; Stummeyer K; Berger M; Vogel U; Costantino P; Gerardy-Schahn R
    Glycobiology; 2014 Feb; 24(2):150-8. PubMed ID: 24259400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping the binding domains on meningococcal Opa proteins for CEACAM1 and CEA receptors.
    de Jonge MI; Hamstra HJ; van Alphen L; Dankert J; van der Ley P
    Mol Microbiol; 2003 Nov; 50(3):1005-15. PubMed ID: 14617157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential of recombinant opa proteins as vaccine candidates against hyperinvasive meningococci.
    Callaghan MJ; Lewis S; Sadarangani M; Bailey SE; Chan H; Ferguson DJ; Derrick JP; Feavers I; Maiden MC; Pollard AJ
    Infect Immun; 2011 Jul; 79(7):2810-8. PubMed ID: 21464082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and characterisation of outer membrane vesicle vaccines against serogroup A Neisseria meningitidis.
    Norheim G; Aase A; Caugant DA; Høiby EA; Fritzsønn E; Tangen T; Kristiansen P; Heggelund U; Rosenqvist E
    Vaccine; 2005 May; 23(29):3762-74. PubMed ID: 15893613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation.
    de Waal Malefyt R; Yssel H; de Vries JE
    J Immunol; 1993 Jun; 150(11):4754-65. PubMed ID: 7684412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human T-cell responses after vaccination with the Norwegian group B meningococcal outer membrane vesicle vaccine.
    Naess LM; Oftung F; Aase A; Wetzler LM; Sandin R; Michaelsen TE
    Infect Immun; 1998 Mar; 66(3):959-65. PubMed ID: 9488382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.